Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

IMPORTANCE: No retrospective cohort study has assessed the effectiveness of semaglutide at doses used in randomized clinical trials to treat obesity (ie, 1.7 and 2.4 mg). OBJECTIVE: To study weight loss outcomes associated with semaglutide treatment at doses used in randomized clinical trials for pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghusn, Wissam, De la Rosa, Alan, Sacoto, Daniel, Cifuentes, Lizeth, Campos, Alejandro, Feris, Fauzi, Hurtado, Maria Daniela, Acosta, Andres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486455/
https://www.ncbi.nlm.nih.gov/pubmed/36121652
http://dx.doi.org/10.1001/jamanetworkopen.2022.31982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486455/
https://www.ncbi.nlm.nih.gov/pubmed/36121652
http://dx.doi.org/10.1001/jamanetworkopen.2022.31982

Ejemplares similares